Sprout Pharmaceuticals - Articles and news items

Valeant to acquire Sprout for $1 billion

Industry news / 20 August 2015 / Victoria White

Valeant has entered into a definitive agreement to acquire Sprout, makers of female libido drug Addyi, for approximately $1 billion…

FDA approves female libido drug Addyi

Industry news / 19 August 2015 /

The US FDA has approved Sprout’s Addyi (flibanserin) to treat acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+